Documenti analoghi

• Interferon‐gamma blocking as a promising treatment for severe liver dysfunction in secondary hemophagocytic lymphohistiocytosis after liver transplantation
  di: Chen Chen, et al.
  Pubblicazione: (2025)
• Impact of cystic fibrosis transmembrane conductance regulator modulator therapies on liver stiffness and liver enzymes: An observational perspective single‐center cohort study
  di: Laura Giugliano, et al.
  Pubblicazione: (2026)
• Preliminary evidence of improved liver biomarkers in adolescents with obesity and suspected metabolic dysfunction‐associated steatotic liver disease treated with semaglutide: A case series
  di: Rachel Schenker, et al.
  Pubblicazione: (2025)
• Odevixibat as an adjunctive treatment for refractory pruritus in rare variants of cholestatic liver disease
  di: Akshat Goel, et al.
  Pubblicazione: (2024)
• B cell depletion for autoimmune liver diseases: A retrospective review of indications and outcomes
  di: Guillermo A. Costaguta, et al.
  Pubblicazione: (2024)